NCT02196636View on ClinicalTrials.gov

A Phase 1 Study of RO6806127 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Matching placebo, administered orally with approximately 240 mL of buffer

DRUG

RO6806127

Administered orally with approximately 240 mL of buffer

Trial Locations (1)

08053

Marlton

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02196636 - A Phase 1 Study of RO6806127 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter